In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands (Q39952629)

15 September 2017

In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands (English)

1 reference

15 September 2017

3

1 reference

15 September 2017

4

1 reference

15 September 2017

16

1 reference

15 September 2017

Michael Groessl

7

0 references

Muhammad Hanif

Muhammad Hanif

2

0 references

Maxim L. Kuznetsov

Maxim L Kuznetsov

6

0 references

Michael A. Jakupec

Michael A Jakupec

13

0 references

Paul Dyson

Paul J Dyson

Lucienne Juillerat-Jeanneret

15

0 references

14

Lucienne Juillerat-Jeanneret

1 reference

15 September 2017

11

Vladimir B Arion

1 reference

15 September 2017

12

Markus Galanski

1 reference

15 September 2017

10

Florian Biba

1 reference

15 September 2017

9

Olivier Zava

1 reference

15 September 2017

Isabella Berger

1

1 reference

15 September 2017

Roland O John

5

1 reference

15 September 2017

Frederic Schmitt

8

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Chemistry—A European Journal

15 September 2017

1 reference

15 September 2017

14

1 reference

15 September 2017

9046-9057

1 reference

15 September 2017

29

1 reference

Platinum Compounds: a New Class of Potent Antitumour Agents

15 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Complexes of metals other than platinum as antitumour agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Two dimensional separation schemes for investigation of the interaction of an anticancer ruthenium(iii) compound with plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: a novel approach for the analysis of anticancer metallodrugs in human serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and anti

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

A viable hydrogen-storage system based on selective formic acid decomposition with a ruthenium catalyst

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Metal-based antitumour drugs in the post genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Modifying the structure of dinuclear ruthenium complexes with antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Synthesis and crystal structure of an open capsule-type octanuclear heterometallic sulfide cluster with a linked incomplete double cubane framework without an intramolecular inversion center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Platinum group metallodrug-protein binding studies by capillary electrophoresis - inductively coupled plasma-mass spectrometry: a further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Characterization of interactions between human serum albumin and tumor-inhibiting amino alcohol platinum(II) complexes using capillary electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

CE in anticancer metallodrug research--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

High Accuracy Molecular Weight Determination and Variation Characterization of Proteins Up To 80 ku by Ionspray Mass Spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Analysis of platinum adducts with DNA nucleotides and nucleosides by capillary electrophoresis coupled to ESI-MS: indications of guanosine 5'-monophosphate O6-N7 chelation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Capillary electrophoresis in anti-cancer metallodrug research: advances and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Ruthenium antimetastatic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

16. (η6-Hexamethylbenzene)Ruthenium Complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Density-functional thermochemistry. III. The role of exact exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Quantum Calculation of Molecular Energies and Energy Gradients in Solution by a Conductor Solvent Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Synthesis and characterisation of [(η6-cymene)Ru(L)X2] compounds: single crystal X-ray structure of [(η6-cymene)Ru(P{OPh}3)Cl2] at 203 K

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Mass spectrometric analysis of ubiquitin–platinum interactions of leading anticancer drugs: MALDI versus ESI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.200801032

Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2007.698

8 July 2023

Identifiers

DOI

10.1002/CHEM.200801032

1 reference

15 September 2017

1 reference